CHINA PHARMA HOLDINGS, INC. Interest Expense, Other
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Interest Expense, Other of $6.80 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. interest expense, other for the quarter ending 2026-06-30 was $6.80K, a 29.74% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for the quarter ending 2025-12-31 was $22.60K, a 23.97% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for the quarter ending 2025-09-30 was $24.05K, a 29.51% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for the quarter ending 2025-06-30 was $9.68K, a 79.90% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for fiscal 2025 was $102.04K, a 33.80% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for fiscal 2024 was $154.14K, a 53.79% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for fiscal 2023 was $333.60K, a 526.09% increase from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. interest expense, other for fiscal 2022 was $53.28K, a 147.51% increase from fiscal 2021.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 3 month as first filed | Interest Expense, Other 6 month | Interest Expense, Other 6 month as first filed | Interest Expense, Other 9 month | Interest Expense, Other 12 month | Interest Expense, Other 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.80K 10-Q · filed 2026-08-14 | $13.27K 10-Q · filed 2026-08-14 | |||||
| 2025-12-31 | $22.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $46.65K derived: sum of 2 quarters · filed 2026-04-01 | $56.33K derived: sum of 3 quarters · filed 2026-08-14 | $102.04K 10-K · filed 2026-04-01 | |||
| 2025-09-30 | $24.05K 10-Q · filed 2025-11-12 | $33.72K derived: sum of 2 quarters · filed 2026-08-14 | $79.43K 10-Q · filed 2025-11-12 | $91.48K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $9.68K 10-Q · filed 2026-08-14 | $27.36K 10-Q · filed 2025-08-14 | $19.59K 10-Q · filed 2026-08-14 | $55.39K 10-Q · filed 2025-08-14 | $67.44K derived: sum of 3 quarters · filed 2026-08-14 | $101.55K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $28.03K 10-Q · filed 2025-05-14 | $57.76K derived: sum of 2 quarters · filed 2026-04-01 | $91.87K derived: sum of 3 quarters · filed 2026-04-01 | $140.01K derived: sum of 4 quarters · filed 2026-04-01 | |||
| 2024-12-31 | $29.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $63.84K derived: sum of 2 quarters · filed 2026-04-01 | $111.98K derived: sum of 3 quarters · filed 2026-04-01 | $154.14K 10-K · filed 2026-04-01 | |||
| 2024-09-30 | $34.11K 10-Q · filed 2025-11-12 | $82.25K derived: sum of 2 quarters · filed 2025-11-12 | $124.41K 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | $48.14K 10-Q · filed 2025-08-14 | $90.30K 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | $42.16K 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | $333.60K 10-K · filed 2025-03-31 | $31.75K 10-K · filed 2024-04-01 | |||||
| 2023-06-30 | $148.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $151.56K 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $3.39K 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | $53.28K 10-K · filed 2024-04-01 | ||||||
| 2022-06-30 | $127.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $131.27K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | $3.39K 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | $21.53K 10-K · filed 2023-03-30 | ||||||
| 2020-12-31 | $22.26K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |